Quantification of 3‐month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam

[1]  R. Post,et al.  The emerging role of cytochrome P450 3A in psychopharmacology. , 1995, Journal of clinical psychopharmacology.

[2]  R L Slaughter,et al.  Recent Advances: the Cytochrome P450 Enzymes , 1995, The Annals of pharmacotherapy.

[3]  P. Watkins,et al.  The erythromycin breath test predicts the clearance of midazolam , 1995, Clinical pharmacology and therapeutics.

[4]  W. Trager,et al.  Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients. , 1994, The Journal of pharmacology and experimental therapeutics.

[5]  W. Trager,et al.  Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation. , 1994, The Journal of pharmacology and experimental therapeutics.

[6]  P. Watkins.  Noninvasive tests of CYP3A enzymes. , 1994, Pharmacogenetics.

[7]  J. Groopman,et al.  Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men , 1993, Clinical pharmacology and therapeutics.

[8]  W. Jusko,et al.  Gender‐based effects on methylprednisolone pharmacokinetics and pharmacodynamics , 1993, Clinical pharmacology and therapeutics.

[9]  C. Hunt,et al.  Effect of age and gender on the activity of human hepatic CYP3A. , 1992, Biochemical pharmacology.

[10]  C. DeVane,et al.  Influence of menstrual cycle and gender on alprazolam pharmacokinetics , 1991, Clinical pharmacology and therapeutics.

[11]  P. Watkins,et al.  Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. , 1989, The Journal of clinical investigation.

[12]  K. Wilson.  Sex-Related Differences in Drug Disposition in Man , 1984, Clinical pharmacokinetics.

[13]  D. Breimer,et al.  Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam. , 1982, British journal of clinical pharmacology.

[14]  J. Tillement,et al.  Influence of Sex on Drug Kinetics in Man , 1977, Clinical pharmacokinetics.

[15]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[16]  M. McCarron,et al.  Clinical Pharmacy: Case Studies , 1974 .

[17]  F. Gonzalez.  Cytochrome P450 in humans , 1993 .

[18]  A. Okey.  Enzyme induction in the cytochrome P-450 system. , 1990, Pharmacology & therapeutics.

[19]  P. Skett.  Biochemical basis of sex differences in drug metabolism. , 1988, Pharmacology & therapeutics.

[20]  S. Meisel.  Gentamicin pharmacokinetics. , 1978, American journal of hospital pharmacy.

[21]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .